REGEN BIOPHARMA, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $353.6K
Liabilities Breakdown FY2023
Total Liabilities: $5.5M
Asset Breakdown
Total Assets: $353.6K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $121.0K | 34.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $232.6K | 65.8% |
Liabilities Breakdown
Total Liabilities: $5.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $29.7K | 0.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.4M | 99.5% |